Oct 14 2024
A large-scale study involving over 100,000 participants has found that maternal marijuana use during early pregnancy is not associated with an increased risk of offspring developing attention deficit hyperactivity disorder (ADHD) or disruptive behavior disorders (DBD). The study, titled Prenatal Cannabis Use and Offspring Attention Deficit Hyperactivity Disorder and Disruptive Behavior Disorders: A Retrospective Cohort …
Oct 12 2024
2024 has proven to be a landmark year for the research of marijuana and its compounds such as THC and CBD. As marijuana rescheduling to Schedule III looms, the path for future research could soon become even smoother. However, even without this change, significant strides have already been made. Below are the top marijuana, THC, …
Oct 10 2024
Researchers from Jiamusi University, Tianjin First Central Hospital, and Nankai University in China have developed a novel CBD-loaded hydrogel system that may offer a new therapeutic approach for chronic inflammatory bowel disease (IBD), according to a new study. Published in the Journal of Applied Biomaterials & Functional Materials, the study addresses the growing incidence of …
Oct 10 2024
A study conducted by researchers from Colorado State University, published in Frontiers in Veterinary Science, evaluated the effects of cannabidiol (CBD) on dogs with mobility impairments. The double-blind, crossover, placebo-controlled study involved 42 dogs, with 38 completing the trial. For the study, dogs were randomly assigned to receive either CBD oil or a placebo over …
Oct 10 2024
A study published in the Journal of Cannabis Research and accessible online via the U.S. National Library of Medicine investigated the association between cannabis use and physical activity in the United States. The research, conducted by researchers from Brigham Young University, examined how cannabis legalization and health status influenced this relationship, using data from the …
Oct 09 2024
A recent study published in BMC Neuroscience highlights psilocybin’s potential neuroprotective effects. Conducted by researchers from Taiwan National Health Research Institutes, China Medical University, and University Hospitals of Cleveland, the study explored how psilocybin—a 5HT2A receptor agonist found in “magic mushrooms”—can reduce brain damage and enhance neurological recovery after stroke. The study involved adult male …
Oct 09 2024
A new study conducted by researchers from the University of Colorado Anschutz Medical Campus and the University of Colorado Boulder has found that edible cannabis may provide both short-term and extended relief for individuals suffering from chronic low back pain. The study, published in the peer-reviewed journal Frontiers in Pharmacology, examined the effects of edible …
Oct 08 2024
Psilocybin, the psychoactive compound found in magic mushrooms, could revolutionize the treatment of major depressive disorder (MDD), according to a new study that analyzed multiple clinical trials. For the study, researchers from several Chinese institutions, including The First Affiliated Hospital of Hainan Medical University and Guangzhou Medical University, conducted a systematic review of five randomized …
Oct 07 2024
According to a study published recently in the journal Clinical Therapeutics, there is significant variations in medical marijuana use based on patients’ medical conditions. Researchers from the University of Southern California, Brandeis University, and Monash University in Australia analyzed data from over 16,000 patients who purchased medical cannabis from dispensaries in New York over a …
Oct 07 2024
In a new study, scientists have uncovered a powerful new use for abnormal cannabinoid (AbnCBD) derivatives. These unique compounds, distinct from traditional cannabinoids, have shown remarkable effectiveness in combating drug-resistant Candida species, notes the study’s researchers. Published in Pharmacological Research, the study reveals how these derivatives not only inhibit fungal growth but also disrupt biofilm …
